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The sobering facts are that over one-third of the popula-
tion of the United States is overweight and one-fifth is
obese as defined as a body mass index (BMI) ≥ 30 kg/m2
(Table 1). As a society, Americans spend over 140 billion
healthcare dollars trying to treat the epidemic. The mag-
nitude of the problem is most evident in comparing obe-
sity trends among US adults from 1985 to 2000 with a
noted rise in the super obese. The population with a BMI
≥ 30 kg/m2 has increased twofold, with a BMI ≥ 40 kg/m2
has increased fourfold and with a BMI ≥ 50 kg/m2 has
increased fivefold (Figure 1).1
The disease of obesity is spreading past the boundaries
of North America to all countries and cultures. The World
Health Organization (WHO) reports that one billion
adults are overweight, and 300 million are obese. In 2002,
the WHO reported that obesity contributes to diabetes,
ischaemic heart disease and certain cancers.2 Obesity is 
no longer a disease of the middle-aged. Obesity is now
becoming more and more prevalent among our children
and adolescents.
Obesity is not just about how you look. Increased body
weight is associated with numerous comorbid conditions.
These illnesses include hypertension, hyperlipidaemia,
coronary artery disease, congestive heart failure, diabetes
mellitus, sleep apnoea, hypoventilation syndrome, gastro-
oesophageal reflux, urinary incontinence, venous insuffi-
ciency, pseudotumour cerebri, osteoarthritis and cancer.
Most of these comorbid conditions severely affect quality
of life. Unchecked, obesity leads to significant disease and
decrease in life expectancy. For example, in obese adoles-
cents 55 years later, obesity increases heart disease 230%,
increases cerebral vascular mortality 1,300% and increases
colorectal cancer mortality 900%.2 And in the United
States, morbid obesity with a BMI > 45 as a young adult
decreases life expectancy. Black males will lose 22 years,
white males 12 years, white females 8 years and black
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Figure 1. Increase in prevalence of obesity in the United States.
With permission from reference 1.
Table 1. Body mass index is the indicator of excess body fat
kg/m2
Overweight ≥ 25
Obese ≥ 30
Severe obesity ≥ 40
Super obesity ≥ 50
females 4 years.3 But again, there is hope because decreas-
ing weight will frequently reverse these statistics (Table 2).4
As BMI increases, patients are at higher and higher risk of
mortality.5 They are also at higher risk of acquiring comor-
bid illnesses. On the other hand, weight loss often results
in resolution of many of these comorbid illnesses.
Medical therapy is of very limited value, often achiev-
ing 5–10 lb weight loss. Currently, the Food and Drug
Administration (FDA) has approved three medications
for weight loss surgery. Sibutramine (Meridia) is a sero-
tonin and norepinephrine reuptake inhibitor, approved
for 12 months of use, but it needs to be avoided in patients
with hypertension. A second medication, orlistat (Xenical),
is a pancreatic lipase inhibitor, which works by inhibiting
30% of fat absorbed in the diet. Xenical is approved for use
up to 4 years, and it has unwanted side effects of oily stool
spotting and fat-soluble vitamin deficiencies. The only
other medication available in the United States is phenter-
mine (Fastin). Phentermine releases norepinephrine and is
also only approved for short-term use. Unfortunately, phar-
macotherapy even when combined with exercise is unable
to achieve the significant weight loss required for many of
our morbidly and super obese patients. Pharmacotherapy
may have a role when BMI is less than 35 kg/m2.
More and more patients are turning to surgery for
definitive therapy. Surgery is currently the most effective
treatment for obesity with respect to the amount and dura-
tion of weight loss.6 Surgery can achieve dramatic improve-
ment and resolution of existing obesity-related comorbid
conditions. Surgery prevents future comorbid illnesses
and has potential to significantly improve the patient’s
quality of life.7 For these reasons, from 1992 to 2005, there
was an exponential growth in the number of bariatric pro-
cedures performed (Figure 2).8 The most commonly per-
formed weight loss procedure in the United States is the
open gastric bypass; however, laparoscopic gastric bypass
and laparoscopic adjustable gastric band have become
increasingly popular, especially in centres that perform
advanced laparoscopy.
Potential benefits of an operation must be weighed
against the risks. A recent study from the state of
Washington assessed patient survival in a population-
based study.9 In this study, 66,109 obese patients were
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Table 2. Complications of first 70 versus second 70 patients who
underwent laparoscopic gastric bypass
First 70 cases Second 70 cases 
(%) (%)
Leaks 5.7 1.4
Haemorrhage 2.9 0
Bowel obstruction 4.3 2.9
Hernia 2.9 0
Mortality 1.4 0
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Figure 2. Number of weight loss operations in the United States. With permission from reference 8.
reviewed, of whom 3,328 had undergone a bariatric oper-
ation. Patients having weight loss surgery had 11.8% mor-
tality compared to 16.3% in patients who did not undergo
surgery at the 15-year follow-up. Among patients below
40 years of age, the difference in survival after bariatric
surgery was more striking. In this cohort of patients, the
15-year mortality was 13.8% for no surgery but only 3% in
patients who had undergone a bariatric procedure. The
authors concluded that weight loss surgery conferred a
significant survival advantage. Similarly, Christou et al
demonstrated a risk reduction after bariatric surgery com-
pared to diet and exercise.10
For the most part, surgeons in the United States have
adopted the 1991 National Institutes of Health (NIH)
consensus development statement for indications for sur-
gery, which include a BMI > 40 kg/m2 or BMI > 35 kg/m2
with associated high-risk comorbid conditions such as
diabetes and hypertension.6 Moreover, the NIH recom-
mended that weight loss operations be performed by
experienced surgeons, in a clinical setting capable of sup-
porting all aspects of management and assessment. There
also needs to be a commitment both by the patient and
practice to lifelong medical surveillance. In 2006, with the
laparoscopic adjustable band, many surgeons feel that the
criteria are too stringent and limit access to care. Many
surgeons argue that the laparoscopic adjustable band has
lower operative risks and, therefore, should be available
to patients with a BMI of 30 kg/m2. Nevertheless, national
guidelines have not yet adopted lower criteria for differ-
ent operations.
All patients presenting for weight loss surgery are not
acceptable candidates. Patients cannot have high medical
risks, untreated major depression or psychosis, or ongo-
ing alcohol or drug abuse problems. Patients who are
unable to comply with postoperative medical, nutrition
and psychological management are not candidates for
surgery. In the Beth Israel Deaconess Bariatric program,
all patients considering an operation are screened by a
bariatrician (internal medicine physician specializing in
care of the overweight patient), nutritionist and psychol-
ogist prior to being seen by a surgeon. During these visits,
patients need to demonstrate a good understanding of
the risks and benefits of the operation, follow-up and
nutrition.
There have been numerous surgical approaches to
weight loss surgery. Essentially, weight loss operations
can be considered either malabsorption or restrictive 
procedures. Malabsorption procedures include the
jejunoileal bypass, biliopancreatic bypass and duodenal
switch. Restrictive procedures include vertical banded
gastroplasty (VBG) and gastric banding. In the United
States, the gold standard operation is the Roux-en-Y gas-
tric bypass, which is essentially a restrictive procedure
with a small malabsorption component. Jejunoileal bypass
is no longer performed due to complications. Approxi-
mately 1,000 biliopancreatic diversions (BPD) and duo-
denal switch procedures are performed in the United
States each year. As a malabsorption procedure, however,
long-term follow-up is crucial to preventing and manag-
ing metabolic abnormalities. For this reason, the SAGES
consensus statement and the Betsy Lehman report have
identified BPD and duodenal switch as remaining inves-
tigational procedures.8,11 The VBG procedure is rarely
done today; instead, surgeons tend to favour gastric band-
ing procedures as a purely restrictive procedure. In the
United States, the Roux-en-Y gastric bypass remains the
“gold standard”, and among centres offering the mini-
mally invasive approach, the laparoscopic Roux-en-Y gas-
tric bypass is most commonly performed. While plastic
surgeons have popularized liposuction that can remove
20 pounds of subcutaneous fat, liposuction does not sig-
nificantly improve obesity-associated metabolic abnor-
malities and is therefore not considered to be a bariatric
procedure.12 This paper will focus on the two procedures
performed at the Beth Israel Deaconess Medical Center,
Boston, Massachusetts, in the Bariatric Program for sur-
gical weight loss.
The laparoscopic gastric bypass was originally described
by Wittgrove et al in 1996 using a transoral technique 
and a retrocolic, retrogastric Roux limb. They showed
that the procedure was safe and comparable to the open
Roux-en-Y gastric bypass.13 The rationale for a laparo-
scopic approach was to decrease pain, improve postopera-
tive pulmonary function, shorten recovery and return to
full activity and decrease the morbidity associated with a
midline incisional wound. At the Beth Israel Deaconess
Medical Center, we perform the laparoscopic gastric
bypass using six trocars, with the goal of creating a 30 mL
gastric pouch. We use a 75 cm retrocolic, antegastric Roux
limb and 45 cm afferent limb (Figure 3).14 The gastro-
jejunostomy can be created with either a circular stapler
or a linear stapler technique. The jejunojejunostomy is
created with a linear stapler. To date, there is no standard
for linear versus circular anastomosis, antecolic versus
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retrocolic passage of the Roux limb or antegastric versus
retrogastric passage of the Roux limb. Nevertheless, the
principle is that the Roux limb should have no tension.
The pouch should be small and all hernia defects must be
closed to prevent internal hernias. Postoperative day 1
gastrograffin swallow is obtained, which shows the anas-
tomosis without leaks before starting the diet.
We have performed nearly 1,000 bariatric procedures,
but the first 30 patients undergoing laparoscopic gastric
bypass are presented here for benchmarking new pro-
grammes. Patients were mostly female with an average
BMI of 46 kg/m2. Operative time quickly decreased to
slightly over 2 hours. On average, patients would stay in
the hospital 2–3 days. Learning curve is especially impor-
tant and as you compare the first 70 patients with the sec-
ond 70 patients, the incidences of leaks, haemorrhage,
small bowel obstructions, hernias and mortality decreases
(Table 2). In general, laparoscopic gastric bypass has 1%
mortality, 10% complication rate, 5% reoperation rate and
5% conversion to an open approach.15 In expert hands,
the mortality is between 0% and 2%. Initial percentage of
excess weight loss is high after laparoscopic gastric bypass
(Figure 4) and ranges from 68% to 80% in the literature.16
To date, only one study has looked at the long-term out-
come of gastric bypass surgery. Poires et al showed that
after open gastric bypass, 50% excess weight loss was
achievable.17 He had 97% follow-up of gastric bypass 
in 106 gastric bypass patients over 14 years. His study
showed that the weight loss is sustainable. The most
important outcome measure after surgery is the resolu-
tion of comorbid conditions after surgery. Hypertension,
hypercholesterolaemia, diabetes, sleep apnoea and arthri-
tis are all likely to improve if not completely resolve after
weight loss (Table 3).4
The success of gastric bypass surgery depends on long-
term follow-up. Lifetime complications include B12, iron,
folate and vitamin D deficiency, and lack of follow-up can
lead to neurological disorders, anaemia and bone mineral
loss.8 Some patients will require high-dose oral B12, iron
and calcium supplements. Annual lab tests and periodic
assessment of bone density are usually needed. In the first
2 years after surgery, our patients are advised not to
become pregnant, as there is an increased risk of neuro-
logical defects. Even after 2 years post gastric bypass,
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Figure 3. Roux-en-Y gastric bypass. With permission from reference 14.
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Figure 4. Percentage of excess weight loss. Our first 30 patients
were followed for 18 months and, on average, achieved 80%
excess weight loss.
Table 3. Bariatric surgery outcomes: response of comorbidities
to surgically induced weight loss
Aided (%) Improved (%) 
(no need for (reduced 
further treatment) medication dosage)
Asthma 95 100
Diabetes 90–95 100
Dyslipidaemia 70 85
Heart failure 60 90
Hypertension 60–65 90
Sleep apnoea 100 100
With permission from reference 5.
patients who become pregnant require intensive monitor-
ing throughout the pregnancy.
Patients who are morbidly obese are not as healthy as
the general population. Nguyen et al studied the impact of
laparoscopic and open gastric bypass using an SF-36
Health Survey.7 Preoperatively, patients had a lower overall
quality of health. But 3 months after a gastric bypass pro-
cedure, health was restored as measured by physical func-
tioning, role-physical, bodily pain, general health, vitality,
social functioning, role-emotional and mental health.
Nguyen et al further showed modest advantage to the
laparoscopic approach in terms of labour and sexual axis.7
The laparoscopic adjustable gastric band is a purely
restrictive procedure. A belt encircles the cardia of the
stomach to create a small pouch. This is connected to a
catheter. The port is placed under the skin and it is
accessed through a non-coring needle. Saline can be in-
jected into and out of the port, and this will result in a
tightening or loosening of the band, respectively. Like 
the gastric bypass, patients achieve satiety and are often
not hungry. Restriction can be achieved with the lap band
by tightening the band such that patients eat less and they
feel full soon after eating a meal. Liquid foods will pass
easily and the laparoscopic band does not discriminate
between high and low calorie foods. This is unlike the gas-
tric bypass procedure, in which the Roux limb rarely toler-
ates high fats and sweet foods without causing unpleasant
effects of dumping. It is for this reason that the laparo-
scopic adjustable band has varied results. In some patients,
weight loss is similar to the gastric bypass; however, it is
conceivable that weight gain is possible after a lap band 
if a high calorie liquid diet is chosen by the patient. The
lap band was approved by the United States FDA in 2001
after over 100,000 procedures in Europe. It boasts ease of
insertion, reversibility and 30–70% excess weight loss.14
Complications of the laparoscopic adjustable band may
include erosion, prolapse, oesophageal dilatation and
port problems. Patients are quoted a 10% morbidity, and
< 1% perioperative mortality.
Most laparoscopic gastric bands are placed using the
pars flaccida technique (Figure 5).14 A tunnel is created
from the junction of the right and left crura posteriorly
to the left upper quadrant. The catheter is retrieved and
closed around the gastro-oesophageal junction over an
intragastric balloon. We use either a 10 cm band for most
patients or a larger vertical gastrectomy lap band for
patients over 300 pounds. We will routinely perform a
gastrogastric imbrication tacking the anterior cardia to
the neo pouch. This is thought to help decrease anterior
prolapse. One day after surgery, a gastrograffin swallow
confirms proper placement of the band and passage of
contrast through the band. Patients will begin a liquid
diet and in about 6 weeks will be seen in office for possi-
ble band adjustment and tightening. Sometimes, patients
can go 6–12 months without needing an adjustment;
however, other patients find early adjustments necessary
to achieve satiety and restriction.
Clinically, the benefits of laparoscopy include less
pain, better cosmesis and quicker recuperation. The hos-
pital length of stay is 1 day for the band and 2 days for 
the laparoscopic Roux-en-Y gastric bypass. Patients have
less pain, rapid return to normal activity and avoid the
morbidity of an incisional wound.
Unlike many other types of operations performed by
the general surgeon, bariatric surgery requires a team
approach including a bariatrician, nutritionist, bariatric
nurse, psychiatrist, billing person and anaesthesiologist.
The surgeon would need training in advanced laparo-
scopic techniques and also in the care of the bariatric
patient. Hospital resources need to include proper beds,
chairs, lifts, as well as resources from the intensive care
and radiology suites.8 During the last year, the American
Society for Bariatric Surgery and the American College 
of Surgery have established accreditation processes for
hospitals and surgeons. At the Beth Israel Deaconess
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Figure 5. Laparoscopic adjustable band. With permission from ref-
erence 14.
Medical Center, we have now opened a Bariatric Clinic
and Bariatric Unit specifically meeting the needs of our
patients of size.
The Betsy Lehman Center has established best prac-
tice guidelines for all aspects of care for the bariatric
patient, including surgical management, anaesthesia,
nursing and hospital requirements (www.mass.gov/dph/
betsylehman/panel-summary.htm).8 The nine task groups
include surgical care, criteria for patient selection, patient
education, anaesthesia, nursing, paediatric/adolescent,
facility resources, coding and reimbursement, and data
collection. For example, all surgeons performing bariatric
surgery should be board certified and have performed at
least 100 procedures within the previous 2 years. Practices
should include a second surgeon, and patients should be
followed for no less than 5 years. All patients need to be
included in a database, and outcomes of weight loss surgery
should not deviate from norms.
In conclusion, obesity is a disease and epidemic. Once
patients have the disease, simple dieting and exercise are
rarely able to reverse the significant comorbid conditions.
Bariatric surgery, both the laparoscopic band and gastric
bypass, can reverse many of the comorbid illnesses as
patients lose weight and, in so doing, restore health. We
now have superior results with laparoscopy for both the
gastric bypass and the band, and we can boast effective
surgical management, which can achieve sustained weight
reduction and improvement in comorbid illnesses. The
accreditation guidelines of the American College of
Surgeons will further advance best practices and make
operations in our sickest patients as safe as possible.
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